Old Web
English
Sign In
Acemap
>
authorDetail
>
Adriana Albu
Adriana Albu
Yahoo!
Medicine
Pharmacology
Stroke
Internal medicine
Angiotensin II receptor type 1
4
Papers
110
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Angiotensin AT1-receptor blockers and cerebrovascular protection: do they actually have a cutting edge over angiotensin-converting
2009
Roxana Oprisiu
Sébastien Faure
Hakim Mazouz
Florent Boutitie
Jean-Marie Sérot
Jean-Michel Achard
Olivier Godefroy
Olivier Hanon
Mohammed Temmar
Adriana Albu
Svend Strandgaard
Jiguang Wang
Show All
Source
Cite
Save
Citations (0)
Angiotensin AT1-receptor blockers and cerebrovascular protection: do they actually have a cutting edge over angiotensin-converting enzyme inhibitors?
2009
Expert Review of Neurotherapeutics
Roxana Oprisiu-Fournier
Sébastien Faure
Hakim Mazouz
Florent Boutitie
Jean-Marie Sérot
Jean-Michel Achard
Olivier Godefroy
Olivier Hanon
Mohammed Temmar
Adriana Albu
Svend Strandgaard
Ji-Guang Wang
Sandra E. Black
Albert Fournier
Show All
Source
Cite
Save
Citations (10)
Prevention of dementia by antihypertensive drugs: how AT1-receptor-blockers and dihydropyridines better prevent dementia in hypertensive patients than thiazides and ACE-inhibitors
2009
Expert Review of Neurotherapeutics
Albert Fournier
Roxana Oprisiu-Fournier
Jean-Marie Sérot
Olivier Godefroy
Jean-Michel Achard
Sébastien Faure
Hakim Mazouz
Mohamed Temmar
Adriana Albu
Régis Bordet
Olivier Hanon
François Gueyffier
Ji-Guang Wang
Sandra E. Black
Naoyuki Sato
Show All
Source
Cite
Save
Citations (99)
The crossover comparative trial of calcium acetate versus sevelamer hydrochloride (Renagel) as phosphate binders in dialysis patients.
2000
American Journal of Kidney Diseases
A. Fournier
Roxana Oprisiu
Adriana Albu
Dungaciu M
el Esper N
Mornière P
Show All
Source
Cite
Save
Citations (1)
1